β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Yepakati Yakanyanya Kuchena Yakaratidzwa Mufananidzo

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Tsanangudzo Pfupi

Zita: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9

Chitarisiko: Muchena kana Kunze-Ichena Crystalline Powder

Chiyero: ≥99.0% (HPLC)

Pakati peClofarabine (CAS: 123318-82-1) mukurapa kweVana vane Acute Lymphoblastic Leukemia (ALL)

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Commercial Supply Clofarabine Related Intermediates:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Chemical Properties:

Chemical Name	β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Mashoko anoreva zvakafanana	1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Nhamba yeCAS	6974-32-9
Nhamba yeCAT	RF-PI222
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C28H24O9
Molecular Weight	504.49
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Ichena kana Isina-White Crystalline Powder
Assay / Analysis Method	≥99.0% (HPLC)
Melting Point	126.0~133.0℃
Kurasika paKuomesa	≤0.50%
Residue paIgnition	≤0.50%
Zvose Zvisina Kuchena	≤1.00%
Heavy Metals	≤20ppm
Test Standard	Enterprise Standard
Usage	Pharmaceutical Pakati peClofarabine CAS: 123318-82-1

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

FAQ:

Application:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) iri pakati pe (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) inova purine nucleoside anticancer drugs inotanga kubudirira kugadzirwa neTop10 biopharmaceutical company yeUnited States-Genzyme Corporation ine mazita ekutengesa ari "Clofarabine".Musi wa28 Zvita 2004 iyo US food and Drug Administration (FDA) yakashandisa kukurumidza-track kubvumidza clofarabine kuti ishandiswe kuvana vane refractory kana relapsed acute lymphocytic leukemia (ALL);ine simba rakanakisa pakurapa leukemia nekushivirira zvakanaka uye pasina maitiro asina fungidziro akashata.Inogona kupihwa kuburikidza nekupihwa intravenously kana kupihwa nemuromo.Mushonga uyu ndiwo wekutanga kubvumidzwa kuti upiwe kurapwa kwevana leukemia mumakore anopfuura gumi.